- 全部删除
您的购物车当前为空
Leuxinostat 是一种HDAC抑制剂,对hHDAC6的IC50为30 nM。它能够抑制THP1、K562、U937和MEK1细胞的增殖,同时诱导白血病细胞NB4和MOLT-4发生细胞凋亡 (apoptosis)。另外,Leuxinostat 能抑制造血干细胞的扩增,并且在斑马鱼模型中展现出抗白血病活性。
Leuxinostat 是一种HDAC抑制剂,对hHDAC6的IC50为30 nM。它能够抑制THP1、K562、U937和MEK1细胞的增殖,同时诱导白血病细胞NB4和MOLT-4发生细胞凋亡 (apoptosis)。另外,Leuxinostat 能抑制造血干细胞的扩增,并且在斑马鱼模型中展现出抗白血病活性。

Leuxinostat 相关产品
| 产品描述 | Leuxinostat, an inhibitor of HDAC, exhibits an IC50 of 30 nM against hHDAC6. It suppresses the proliferation of THP1, K562, U937, and MEK1 cells, while also inducing apoptosis in leukemia cells NB4 and MOLT-4. Additionally, Leuxinostat inhibits the expansion of hematopoietic stem cells and demonstrates anti-leukemic activity in a zebrafish model. |
| 靶点活性 | HDAC1 (human):1.203 μM, HDAC11 (human):5.57 μM, HDAC3 (human):2.858 μM, HDAC8 (human):2.446 μM, HDAC6 (human):0.03 μM, HDAC10 (human):4.811 μM |
| 分子式 | C18H20N4O4 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容